Clinical Trial

Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury

Study acronym: MSC-AKI-001
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2026 (before its estimated August 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial is to evaluate the efficacy and safety of Amimestrocel (human umbilical cord mesenchymal stromal cells) in the treatment of AKI patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-24; most recent amendment 2026-07-12.
Status change: Not Yet Recruiting → Recruiting 2025-06-26
Trial Details
NCT Number NCT06954740
Lead Sponsor Chinese PLA General Hospital
Conditions Acute Kidney Injury
Enrollment 50 participants
Start Date 2025-06-10
Primary Completion 2026-08-15 (estimated)
Study Completion 2028-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14